Scientific Advisory Committee
Scientific Advisory Committee
Core Team
Core team
Board of Directors
Board of Directors
  • Shi Hepeng
    Founder, Chairman and CEO of Avistone

    Doctor of Microbiology and Biochemical Pharmacy, Chinese Academy of Medical Sciences & Peking Union Medical College. Beijing Science and Technology Rising Star, Beijing Top 100 Leading Talents, and Beijing High-level Innovation and Entrepreneurship Talents.
    Responsible for the development, commercialization of the company's innovative drugs, and company operation. With more than 17 years of working experience in large pharmaceutical companies and innovative biotechnology companies, he has engaged in early drug development, clinical study, industrial production, and commercial development. He has a deep understanding of the development of the biomedical industry. and is skilled in operation of innovation-based enterprises. Shi has led Purun'ao to become a leading enterprise and a member of the inaugural batch of companies in Beijing Biopharmaceutical Industry Breakthrough Development Project (also known as G20 Project).
    He has previously taken multiple executive positions including Executive Deputy General Manager of Yangzijiang Pharmaceutical Group Beijing Haiyan Pharmaceutical Co., Ltd., and Group R&D Director and BD Director of Harbin Gloria Pharmaceuticals Co.,Ltd. He launched the production of "Suhuang Zhike Capsules" with an annual sales of 2 billion yuan in Beijing, and led Yangzijiang Beijing Haiyan Pharmaceutical to become a G20 biopharmaceutical enterprise in Beijing.

  • Dr. Lu Hongbo
    Director

  • Dr. Liu Weidong
    Director

  • Dr. Ricky Sun
    Director

  • Zheng Jiaqi, Director
    Director